AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
May 19, 2021 13:10 ET
|
AGC Biologics
Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for...
Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
May 06, 2021 10:00 ET
|
AGC Biologics
Seattle, May 06, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with Oculis to...
Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
April 30, 2021 10:00 ET
|
AGC Biologics
Seattle, April 30, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the expansion of their partnership...
AGC Biologics Expands Partnership with Rocket Pharmaceuticals
April 20, 2021 10:05 ET
|
AGC Biologics
Seattle, April 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership...
AGC Biologics Appoints Jun Takami to General Manager/Site Head of Their Chiba, Japan Site
April 08, 2021 10:00 ET
|
AGC Biologics
Chiba, April 08, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced the appointment of Jun Takami as...
AGC Biologics to Present Their End-to-End Cell and Gene Therapy Offering at ARM’s Meeting on the Mediterranean Conference
April 05, 2021 10:35 ET
|
AGC Biologics
SEATTLE, April 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it will be attending Alliance for...